News | News By Subject | News by Disease News By Date | Search News

Alzheimer's Disease News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
Evotec AG (EVTG.F), Roche (RHHBY)'s Alzheimer's Hopeful Fails Another Trial     7/1/2015
Eli Lilly (LLY) Hits 14-Year High as Investors Await Alzheimer's Data     6/16/2015
Buoyed by Biogen (BIIB), Roche (RHHBY) to Take Another Stab at Anti-Amyloid Alzheimer’s Drugs     6/10/2015
Actavis (ACT) Ordered to Keep Older Alzheimer’s Drug Namenda on the Market     5/26/2015
FORUM Pharma Consolidates Operations in Anticipation of New Growth     5/19/2015
Advancing Biogen (BIIB)’s Alzheimer’s Treatment Could Cost $2.5 Billion Before Knowing if the Drug Works     4/28/2015
In Fight Against Alzheimer's, $100 Million Genentech (RHHBY) Trial in Colombia May Be Ground Zero     4/28/2015
Roche (RHHBY) Still Bullish on Alzheimer’s Research After Biogen (BIIB)’s Successful Clinical Trial     4/22/2015
Targacept (TRGT) Winces As Last Remaining Drug Candidate Flops in Phase II Trial     4/17/2015
Raising $10M in Series A, Alzheon CEO Bets He Can Beat Biogen (BIIB) With World's First Alzheimer's Drug     4/8/2015
AstraZeneca PLC (AZN)'s Failed Cancer Drug Finds New Life in Alzheimer’s Treatment     4/3/2015
Amgen (AMGN)'s deCODE genetics (DCGN) Publishes Largest Human Genome Population Study     3/27/2015
New Research Throws Cold Water on Biogen (BIIB)'s Recent Breakthrough     3/26/2015
Biogen (BIIB) Alzheimer's Drug Aducanumab Exceeds Expectations     3/25/2015
Biogen (BIIB) Drops Idec From Corporate Name, Expands Ambitions in Alzheimer's, ALS     3/24/2015

News from Around the Web
University of Southern California Scientists Look Into Why Most Alzheimer's Patients Are Women     6/29/2015
Middle Age Memory Failures Can Predict Alzheimer's 18 Years Before Diagnosis, Rush University Medical Center Study     6/29/2015
High Blood Pressure Linked To Lower Alzheimer's Risk, Brigham Young University Study     6/29/2015
Blood Type May Boost Alzheimer's Risk, University of Sheffield Study     6/5/2015
DNA Breakage Underlies Both Learning, Age-Related Damage, MIT Study     6/5/2015
Poor Sleep Linked To Alzheimer’s, University of California, Berkeley (CAL) Study     6/3/2015
Memory Loss Not Always First Sign Of Alzheimer’s, National Hospital For Neurology And Neurosurgery Study     5/26/2015
New Link Between Diabetes And Alzheimer’s Discovered, Washington University in St. Louis Study     5/5/2015
Extra Sleep May Restore Memory And Stall Alzheimer’s-Like Condition, Washington University School of Medicine Study     4/27/2015
Can Biogen (BIIB) Really Beat Alzheimer's?     4/24/2015
Brain Scans Give Clues to Link Between Alzheimer's, Down Syndrome, Alzheimer's & Dementia Reveals     4/21/2015
Targacept (TRGT) Abandons Nictoine Focus for Alzheimer's     4/6/2015
Common Epilepsy Drug Restores Brain Function And Memory In Early Alzheimer’s, Johns Hopkins University Study     3/13/2015
Poor Heart Function Could Be Major Alzheimer's Disease Risk, Vanderbilt University Study     3/4/2015
Can Coffee Cut Your MS Risk? Johns Hopkins University Study     3/2/2015

Press Releases
Cerespir Submits Special Protocol Assessment Request To FDA For A Phase III Clinical Trial To Test The Ability Of CSP-1103 To Slow The Progression Of Mild Cognitive Impairment Due To Alzheimer's Disease     7/1/2015
The ALS Association Release: New Clinical Pilot Studies Will Use Biomarkers To Speed Therapy Development     7/1/2015
Anavex (AVXL) To Present Initial Clinical Data From The Phase IIa Clinical Trial Of ANAVEX 2-73 At The Alzheimer’s Association International Conference (AAIC)     6/30/2015
Bioiberica To Trial A New Compound On Human Subjects That Prevents Memory Loss In Patients With Mild Alzheimer's     6/29/2015
Transition Therapeutics Inc. (TTH.TO) Announces Results Of Clinical Study Of ELND005 In Agitation And Aggression In Patients With Alzheimer's Disease     6/24/2015
Heptares Announces Positive Outcome Of Phase 1A Study With First-Ever Selective Muscarinic M1 Receptor Agonist For Improving Cognition In Patients With Alzheimer's Disease     6/17/2015
ALS Guardian Angels Release: Stu Millheiser Discusses A Breakthrough In ALS Treatment Research: Protein Hupf1     6/15/2015
‘Call For Science’ To Find Cure For Alzheimer’s Disease: Health Connexions Launches A Ground-Breaking New $100 Million Program To Fund Alzheimer’s Solutions     6/12/2015
Stemedica Cell Technologies, Inc. Release: FDA Grants IND Approval For Phase Iia Clinical Trial Using Stemedica's itMSC Therapy To Treat Alzheimer's Disease     6/9/2015
Amarantus Diagnostics Announces Acceptance of Two Late-Breaking Abstracts on LymPro Test Data at the 2015 Alzheimer's Association International Conference     6/9/2015
Cytokinetics, Inc. (CYTK) And The ALS Association Announce Partnership To Advance The Fight Against ALS     6/4/2015
Armed With an Ex-GlaxoSmithKline (GSK) Alzheimer's Drug, Axovant Sciences Eyes $251 Million IPO     6/2/2015
Alzheimer's Association Release: New Research Summary: Lifestyle Changes Help Reduce Risk Of Cognitive Decline     6/1/2015
Aphios Granted United States Patent For Alzheimer’s Disease Treatment     5/20/2015
Cambridge Cognition Ltd: New Cloud Based Assessment Tool To Accelerate Development Of Alzheimer’s Treatments     5/20/2015